Abstract
Objective:The definition and management of the atypical nevus remains a controversial issue. Some believe that atypical nevi are common variants of benign melanocytic nevi while others believe they are lesions intermediate between benign melanocytic nevi and melanoma. Therefore, the question of whether or not partially removed atypical nevi should be re-excised with clear margins in order to prevent their evolution into melanoma remains unanswered. Although studies have shown that most atypical nevi will never progress into melanoma, re-excision, when biopsy margins are positive, is commonly practiced. We argue that re-excision in such cases is not necessary.Methods:Our cohort study includes 55 previously biopsied atypical nevi that were not re-excised and which were followed for at least 5 years with a mean follow up time of 6.12 years.Results:The experimental group included 26 atypical nevi whose biopsy revealed at least one involved margin. The control group included 29 atypical nevi whose biopsy revealed clear margins. No melanomas were observed to arise in association with a pre-existing atypical nevus in either the experimental or control group during the follow-up period.Conclusions:The results of our study support observation as a safe alternative to re-excision for incompletely removed atypical nevi. A large prospective study with longer follow up would be necessary to better answer the question of how often atypical nevi evolve into melanoma and over what time period this occurs.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314–1319.NIH Consensus conferenceDiagnosis and treatment of early melanoma.JAMA19922681314-13192. Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol 2001;45:260–276.KanzlerMH]]Mraz-GernhardSPrimary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview.J Am Acad Dermatol200145260-2763. Naeyaert JM, Brochez L. Clinical practice. Dysplastic nevi. N Engl J Med 2003;349:2233–2240.NaeyaertJM]]BrochezLClinical practice. Dysplastic nevi.N Engl J Med20033492233-22404. Barnhill RL. Current status of the dysplastic melanocytic nevus. J Cutan Pathol 1991;18:147–159.BarnhillRLCurrent status of the dysplastic melanocytic nevus.J Cutan Pathol199118147-1595. Bevona C, Goggins W, Quinn T, et al. Cutaneous melanomas associated with nevi. Arch Dermatol 2003;139:1620–1624; discussion 1624.6. Ackerman AB, Mihara I. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. Hum Pathol 1985;16:87–91.AckermanAB]]MiharaIDysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.Hum Pathol19851687-917. Culpepper KS, Granter SR, McKee PH. My approach to atypical melanocytic lesions. J Clin Pathol 2004;57:1121–1131.CulpepperKS]]GranterSR]]McKeePHMy approach to atypical melanocytic lesions.J Clin Pathol2004571121-11318. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996;27:528–531.FarmerER]]GoninR]]HannaMPDiscordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists.Hum Pathol199627528-5319. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers of precursors of cutaneous melanoma? J Am Acad Dermatol 1995;33:1000–1007.Skender-KalnenasTM]]EnglishDR]]HeenanPJBenign melanocytic lesions: risk markers of precursors of cutaneous melanoma?J Am Acad Dermatol1995331000-100710. Brochez J, Verhaeghe E, Grosshans E, et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 2002;196:459–466.BrochezJ]]VerhaegheE]]GrosshansE&etal;Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions.J Pathol2002196459-46611. Halpern AC, Guerry D IV, Elder DE, et al. A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol 1993;100:346S–349S.HalpernAC]]GuerryDIV]]ElderDE&etal;A cohort study of melanoma in patients with dysplastic nevi.J Invest Dermatol1993100346S-349S12. Clark WH Jr, Elder DE, Guerry D IV, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15:1147–1165.ClarkWHJr]]ElderDE]]GuerryDIV&etal;A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.Hum Pathol1984151147-116513. Tripp JM, Kopf AW, Marghoob AA, et al. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol 2002;46:674–682.TrippJM]]KopfAW]]MarghoobAA&etal;Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology.J Am Acad Dermatol200246674-68214. Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol 1975;111: 1588–1590.KornbergR]]AckermanABPseudomelanoma: recurrent melanocytic nevus following partial surgical removal.Arch Dermatol19751111588-159015. Park HK, Leonard DD, Arrington JH III, et al. Recurrent melanocytic nevi: clinical and histologic review of 175 cases. J Am Acad Dermatol 1987;17:285–292.ParkHK]]LeonardDD]]ArringtonJHIII&etal;Recurrent melanocytic nevi: clinical and histologic review of 175 cases.J Am Acad Dermatol198717285-29216. Cohen LM, Hodge SJ, Owen LG, et al. Atypical melanocytic nevi. Clinical and histopathologic predictors of residual tumor at reexcision. J Am Acad Dermatol 1992;27(5 pt 1):701–706.CohenLM]]HodgeSJ]]OwenLG&etal;Atypical melanocytic nevi. Clinical and histopathologic predictors of residual tumor at reexcision.J Am Acad Dermatol1992275 pt 1701-70617. Gambichler T, Senger E, Rapp S, et al. Deep shave excision of macular melanocytic nevi with the razor blade biopsy technique. Dermatol Surg 2000;26:662–666.GambichlerT]]SengerE]]RappS&etal;Deep shave excision of macular melanocytic nevi with the razor blade biopsy technique.Dermatol Surg200026662-66618. Barnhill RL, Hurwitz S, Duray PH, et al. The dysplastic nevus: recognition and management. Plast Reconstr Surg 1988;81:280–289.BarnhillRL]]HurwitzS]]DurayPH&etal;The dysplastic nevus: recognition and management.Plast Reconstr Surg198881280-28919. Ferrandiz L, Moreno-Ramirez D, Camacho FM. Shave excision of common acquired melanocytic nevi: cosmetic outcome, recurrences, and complications. Dermatol Surg 2005;31:1112–1115.FerrandizL]]Moreno-RamirezD]]CamachoFMShave excision of common acquired melanocytic nevi: cosmetic outcome, recurrences, and complications.Dermatol Surg2005311112-111520. Hudson-Peacock MJ, Bishop J, Lawrence CM. Shave excision of benign papular naevocytic naevi. Br J Plast Surg 1995;48:318–322.Hudson-PeacockMJ]]BishopJ]]LawrenceCMShave excision of benign papular naevocytic naevi.Br J Plast Surg199548318-32221. Banky JP, Kelly JW, English DR, et al. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005;141:998–1006.BankyJP]]KellyJW]]EnglishDR&etal;Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.Arch Dermatol2005141998-1006
